CCSD code A1240 – Ventriculoperitoneal shunt creation

Key Takeaways

CCSD Code A1240 covers only the initial creation of a ventriculoperitoneal shunt, not revision or removal.

Hydrocephalus (ICD-10 Q03 congenital, G91 acquired) is the primary clinical indication requiring paired diagnosis submission.

A1240 is distinct from A1430 (shunt removal): using the wrong code is a leading denial trigger for UK private insurers.

Pabau’s claims management software tracks pre-authorisation and CCSD code submission in one workflow, reducing A1240 denial rates.

CCSD Code A1240: Definition and clinical scope

CCSD Code A1240 describes the surgical creation of a ventriculoperitoneal shunt. The code sits within the neurosurgery chapter of the CCSD schedule, which is maintained by the Clinical Coding and Schedule Development group and used by all major UK private medical insurers as the standard procedure billing framework. A1240 applies when a neurosurgeon creates a new shunt from scratch: it does not apply to revisions of an existing shunt or removal of a previously placed system.

The code is billable as a single procedural unit covering the complete shunt construction. Understanding its boundaries is essential before submitting any claim to Bupa, AXA Health, Aviva, Vitality, or any other UK private medical insurer.

What the ventriculoperitoneal shunt creation procedure involves

VP shunt creation is an open neurosurgical procedure performed under general anaesthesia. The operating neurosurgeon places a catheter into one of the brain’s lateral ventricles, connects it to a pressure-regulating valve, and tunnels a distal catheter subcutaneously down the neck and chest wall into the peritoneal cavity. CSF then drains passively when intracranial pressure rises above the valve’s threshold.

The four surgical stages relevant to documenting an A1240 claim are:

1. Burr hole formation: the neurosurgeon drills a burr hole in the skull to allow ventricular access.
2. Ventricular catheter placement: a proximal catheter is passed into the ipsilateral lateral ventricle under fluoroscopic or neuronavigation guidance.
3. Valve insertion: a differential pressure or programmable valve is connected to the proximal catheter and seated sub-galea or sub-cutaneously.
4. Peritoneal catheter tunnelling: the distal catheter is tunnelled subcutaneously and introduced into the peritoneal cavity, either laparoscopically or via a mini-laparotomy.

The operative note must document all four stages to support an A1240 claim. A note that references only ventricular catheter placement without documenting peritoneal placement is a common documentation gap that triggers insurer queries. For guidance on maintaining private practice clinical records that satisfy payer audit requirements, having a structured documentation workflow in place before the procedure is completed saves significant time at the billing stage.

Clinical indications covered by the hydrocephalus shunt CCSD code

Hydrocephalus is the primary clinical indication for VP shunt creation. The condition involves abnormal accumulation of CSF within the ventricular system, causing raised intracranial pressure that can result in neurological deterioration if untreated. A1240 is indicated across all major hydrocephalus subtypes and is also used for other conditions causing raised intracranial pressure that require CSF diversion.

The table below maps the principal clinical indications to their corresponding ICD-10 codes for paired submission:

The specific ICD-10 sub-code chosen must reflect the clinical diagnosis documented in the patient’s records and referral letter. Insurers may query claims where the submitted ICD-10 code does not match the operative note or imaging findings. The table above provides guidance; clinician judgment determines the correct code for each patient.

What CCSD A1240 billing includes and excludes

Knowing A1240’s scope boundaries prevents the most common billing errors. The code covers the entire surgical construction of the VP shunt system as a single bundled procedure. Several related services are excluded and must be billed separately or under a different code.

Anaesthesia billing is the area most likely to vary by insurer contract. Some PMI payers require the anaesthetist’s fees to be submitted on a separate claim; others accept a combined submission. Always verify the current requirement directly with the payer before submitting. This is part of broader private practice billing compliance that practices transitioning from NHS tariff coding often need to reconfigure.

A1240 vs A1430 and adjacent CCSD codes

The most consequential coding distinction in VP shunt billing is between A1240 (creation) and A1430, which covers removal of a cerebroventricular shunt. These two codes describe clinically opposite procedures. Submitting A1430 on a creation claim, or vice versa, is a hard denial trigger at every UK private medical insurer. The comparison below includes other adjacent codes that coders frequently encounter alongside A1240.

Shunt revision is the scenario most likely to cause confusion in practice. When a patient returns with a malfunctioning shunt and requires replacement of one or more components, the correct code is a revision code, not A1240. A1240 is reserved for patients receiving a VP shunt for the first time or, in some cases, receiving a shunt in a new anatomical configuration after a complete explant. Always confirm the current CCSD schedule edition when selecting revision codes, as the schedule is updated periodically by the CCSD technical guide.

Pre-authorisation requirements for CCSD A1240

VP shunt creation is a major elective neurosurgical procedure. All major UK private medical insurers are likely to require pre-authorisation before a claim for A1240 can be accepted, though the specific requirements, evidence standards, and consequences of proceeding without approval vary by payer and by individual policy. Practices should verify current pre-auth rules directly with each insurer before surgery is scheduled.

The clinical evidence typically required when applying for pre-authorisation includes:

• Neuroimaging confirming ventricular dilatation (CT or MRI brain with relevant sequences)
• A neurosurgical consultant letter documenting the clinical indication, failed conservative management where applicable, and the planned procedure
• ICP monitoring data or lumbar puncture CSF pressure readings where available
• Confirmation of the patient’s current insurer membership number and policy status
• The operating neurosurgeon’s GMC registration number

Bupa, AXA Health, and Aviva all operate online and telephone pre-authorisation pathways for neurosurgical procedures. Bupa’s code search portal allows practices to verify whether A1240 requires pre-auth under a specific policy type before the clinical team submits the request. Aviva’s fee schedule similarly sets out procedure-level pre-authorisation flags. Proceeding with surgery without confirmed pre-authorisation typically results in full claim denial with no appeal route, regardless of the clinical necessity of the procedure. This is one of the most important points to flag with the referring team and the patient before any date is set.

For neurosurgical practices managing multiple insurer relationships, tracking which policies have live pre-auth approvals and which are still pending is a significant administrative burden without dedicated software. Pabau’s claims management software includes pre-authorisation tracking so billing teams can see approval status before a claim is submitted, removing one of the most preventable denial triggers.

Manage CCSD claims and pre-authorisation in one place

Pabau helps UK private practices track pre-auth approvals, submit CCSD claims, and maintain the audit-ready documentation that private medical insurers require. See how it works.

Book a demo

Documentation requirements for an A1240 claim

Inadequate documentation is the second most common reason A1240 claims are denied after code errors. Private medical insurers reserve the right to audit any surgical claim and request supporting records. The documentation package for an A1240 submission should include all of the following:

• Operative note: specifying creation (not revision) of the VP shunt, with all four surgical stages documented (burr hole, ventricular catheter, valve, peritoneal catheter). Vague notes such as “shunt inserted” without anatomical detail are insufficient.
• Preoperative neuroimaging report: confirming the radiological diagnosis that justifies surgery (ventricular dilatation, obstructive lesion, or equivalent finding).
• Referral or clinic letter: from the neurosurgical consultant documenting the indication, clinical assessment, and decision for surgical management.
• Anaesthetist’s records: confirming the procedure date and general anaesthetic, particularly if anaesthesia is being billed separately.
• Patient insurer details: current membership number, scheme type, and confirmation that the policy was active on the date of surgery.
• Pre-authorisation reference number: if pre-auth was obtained, the insurer-issued reference number must appear on the claim.
• Operating consultant’s GMC number: required on all private medical insurance claims submitted to UK insurers.

Practices that rely on handwritten or retrospective operative notes face higher audit risk. Structured digital clinical forms completed at the point of care create a more defensible record than documents produced days after the procedure. For practices concerned about general UK data protection compliance in their billing workflows, the ICO requires that patient records used for billing purposes are kept securely and for at least the minimum statutory retention period.

Common reasons A1240 claims are denied

Claim denials on A1240 follow recognisable patterns. Most are preventable. The list below covers the triggers billing teams encounter most frequently when submitting VP shunt creation claims to UK private insurers.

• Wrong procedure code: A1430 (shunt removal) submitted in error instead of A1240. This is the single most common coding denial on VP shunt claims and results from failure to distinguish creation from removal at the point of charge capture.
• Missing pre-authorisation: surgery performed before insurer approval was confirmed. No pre-auth reference number on the claim typically means automatic rejection with no clinical appeal available.
• Absent or vague operative note: notes that do not document the peritoneal placement stage, or that describe a revision procedure without clarifying that a new shunt was created, trigger insurer queries that delay and often result in denial.
• ICD-10 mismatch: the submitted diagnosis code does not match the clinical indication in the operative note or referral letter. A Q03 congenital hydrocephalus code submitted for a patient whose imaging shows post-traumatic hydrocephalus (G91.3) creates an inconsistency that prompts rejection.
• Congenital condition policy exclusion: some PMI policies exclude treatment for congenital conditions. A1240 claims coded with Q03 (congenital hydrocephalus) may be denied under these clauses. Practices should verify policy exclusions before scheduling surgery when the diagnosis is congenital.
• Claim submitted outside the insurer’s time limit: insurers set deadlines for claim submission (often 3-6 months from the date of service, though this varies and changes). Late submission results in denial regardless of clinical validity.
• Anaesthesia bundled incorrectly: anaesthetist fees included on the surgeon’s claim when the insurer expects a separate submission, or vice versa.
• GMC number absent: the operating consultant’s GMC registration number missing from the claim form.

Tracking denial patterns across CCSD neurosurgery claims helps practices identify whether denials cluster around a particular insurer, code type, or documentation gap. Pabau’s reporting and analytics tools can surface these patterns at a practice level, supporting the kind of systematic denial management that reduces write-offs over time.

How to appeal a denied A1240 claim

When a denial is received, the remittance advice will state the reason code. Most UK private insurers provide a formal appeals or reconsideration pathway. The steps below apply to the majority of A1240 denial scenarios:

1. Identify the denial reason from the insurer’s remittance or rejection letter. Confirm whether the denial is administrative (wrong code, missing pre-auth reference, late submission) or clinical (policy exclusion, medical necessity dispute).
2. Gather supporting documentation specific to the denial reason: if the issue is the operative note, obtain a corrected or supplementary statement from the neurosurgeon; if the issue is the ICD-10 code, obtain a letter confirming the clinical diagnosis.
3. Write a consultant covering letter addressing the stated denial reason directly. The letter should be on hospital or clinic headed paper, signed by the operating neurosurgeon, and include their GMC number.
4. Resubmit within the insurer’s appeal window, which is typically 30-90 days from the denial date. Include the original claim reference, the denial reason code, and all supporting documents.
5. Escalate to the insurer’s clinical review team if the first-level appeal fails on clinical grounds. This involves requesting a peer-to-peer review between the insurer’s medical advisor and the treating neurosurgeon.

Appeals for administrative denials (missing pre-auth reference, wrong code) are generally resolved at step 2 with a corrected resubmission. Clinical appeals take longer and benefit from the neurosurgeon’s direct involvement. Practices using structured billing workflows tend to have better appeal outcomes because supporting documentation is readily accessible rather than reconstructed after the fact.

How Pabau supports CCSD neurosurgery billing

Neurosurgical private practices billing A1240 and adjacent CCSD codes face a specific administrative challenge: the procedures are high-value, the payer requirements are exacting, and the documentation volume per claim is substantial. Pabau is designed for UK private practices and includes several features that address these pressure points directly.

Pabau’s claims management tools support CCSD code lookup and submission tracking, pre-authorisation status monitoring per patient and per insurer, and an audit trail linking the clinical note to the submitted claim. For practices also concerned about CQC compliance obligations in England, Pabau’s record-keeping functionality helps maintain the documentation standards inspectors review. The platform’s private practice management capabilities extend beyond billing: appointment scheduling, digital consent, and insurer correspondence can all be managed within the same system, reducing the administrative overhead that neurosurgical secretaries currently handle across multiple disconnected tools.

For practices processing multiple CCSD neurosurgery claims per month, reducing the denial rate on high-value codes like A1240 has a material impact on revenue. Pabau’s workflow keeps pre-auth approvals, operative documentation, and insurer submission in one place, closing the gaps where denials most commonly originate.

Conclusion

CCSD Code A1240 covers a single, clearly defined procedure: the surgical creation of a ventriculoperitoneal shunt. Most denials on this code trace back to three fixable problems: using A1430 instead of A1240, missing pre-authorisation, or submitting without a complete operative note. Address those three points before submission and the majority of A1240 claim failures are preventable.

Pabau’s practice management platform is built for UK private practices handling CCSD billing, with pre-auth tracking and claims workflows that reduce the administrative gaps that turn preventable errors into denied revenue. To see how it handles neurosurgery billing, book a demo.

Continue your research

Need to understand the Bupa CCSD fee schedule? Bupa CCSD codes guide covers how Bupa reimburses CCSD-coded procedures, fee schedule structure, and submission requirements.

Want to reduce private practice admin overhead? Features that save private practices time covers the Pabau tools most used by UK private consultants and their secretarial teams.

Managing multiple insurer relationships? Private practice management guide explains how to structure billing workflows, track pre-auth, and maintain compliance across Bupa, AXA, and Aviva.

Frequently Asked Questions